Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | parathyroid hormone 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | oxidoreductase GMC-type | 0.0138 | 0.4448 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.0507 | 0.0507 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0915 | 0.5 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0915 | 0.0915 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0915 | 0.2058 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0915 | 0.5 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 1 | 1 |
Echinococcus granulosus | lamin | 0.0033 | 0.0507 | 0.0507 |
Echinococcus multilocularis | lamin | 0.0033 | 0.0507 | 0.0507 |
Mycobacterium ulcerans | hypothetical protein | 0.0138 | 0.4448 | 0.5 |
Mycobacterium leprae | possibleputative FAD-linked oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0507 | 0.0507 |
Schistosoma mansoni | hypothetical protein | 0.0138 | 0.4448 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0915 | 0.0915 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1544 | 0.1544 |
Mycobacterium ulcerans | FAD-linked oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.1471 | 0.3307 |
Wolbachia endosymbiont of Brugia malayi | 2-polyprenyl-6-methoxyphenol 4-hydroxylase | 0.0138 | 0.4448 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0507 | 0.0507 |
Trypanosoma brucei | Monooxygenase, putative | 0.0138 | 0.4448 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0138 | 0.4448 | 0.5 |
Mycobacterium ulcerans | membrane-associated oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.0507 | 0.0507 |
Mycobacterium ulcerans | oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0915 | 0.0915 |
Trypanosoma cruzi | Monooxygenase, putative | 0.0138 | 0.4448 | 0.5 |
Echinococcus multilocularis | protein MICAL 3 | 0.0138 | 0.4448 | 0.4448 |
Trypanosoma brucei | kynurenine 3-monooxygenase, putative | 0.0138 | 0.4448 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0915 | 0.2058 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0829 | 0.1865 |
Echinococcus multilocularis | ubiquinone biosynthesis monooxygenase COQ6 | 0.0138 | 0.4448 | 0.4448 |
Toxoplasma gondii | FAD binding domain-containing protein | 0.0138 | 0.4448 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1544 | 0.1544 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.0507 | 0.0507 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1544 | 0.1544 |
Plasmodium vivax | FAD-dependent monooxygenase, putative | 0.0138 | 0.4448 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1544 | 0.1544 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.1471 | 0.3307 |
Echinococcus granulosus | ubiquinone biosynthesis monooxygenase COQ6 | 0.0138 | 0.4448 | 0.4448 |
Loa Loa (eye worm) | hypothetical protein | 0.0138 | 0.4448 | 0.4448 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0915 | 0.5 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0138 | 0.4448 | 0.5 |
Mycobacterium ulcerans | FAD-dependent oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0829 | 0.0829 |
Toxoplasma gondii | FAD binding domain-containing protein | 0.0138 | 0.4448 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0138 | 0.4448 | 0.5 |
Schistosoma mansoni | monoxygenase | 0.0138 | 0.4448 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0485 | 0.0485 |
Plasmodium falciparum | FAD-dependent monooxygenase, putative | 0.0138 | 0.4448 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0507 | 0.0507 |
Onchocerca volvulus | 0.0058 | 0.1471 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 1 | 1 |
Schistosoma mansoni | lamin | 0.0033 | 0.0507 | 0.114 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0507 | 0.0507 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0829 | 0.0829 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Echinococcus multilocularis | musashi | 0.0033 | 0.0507 | 0.0507 |
Mycobacterium ulcerans | hypothetical protein | 0.0138 | 0.4448 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0138 | 0.4448 | 0.5 |
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.0507 | 0.114 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0507 | 0.0507 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.1471 | 0.1471 |
Echinococcus granulosus | protein MICAL 3 | 0.0138 | 0.4448 | 0.4448 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0138 | 0.4448 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0915 | 0.5 |
Chlamydia trachomatis | monooxygenase | 0.0138 | 0.4448 | 0.5 |
Schistosoma mansoni | lamin | 0.0033 | 0.0507 | 0.114 |
Mycobacterium ulcerans | oxidoreductase | 0.0138 | 0.4448 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 50 uM | PUBCHEM_BIOASSAY: Factor XIIa 1536 HTS Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID800] | ChEMBL. | No reference |
Potency (functional) | 0.0029 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 11.2202 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.581 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 25.929 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.